Investor Overview

Investor Presentation
Financial News
Jun 26, 2019

Scientists at the NIH and FDA Demonstrate Impressive Synergy of MDNA55 with Interferons TORONTO and HOUSTON, June 26, 2019 /CNW/ - Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:...

Jun 25, 2019

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immunotherapy company, today announced its operational and financial results for the year...

Stock Quote
Stock Chart
Upcoming Events
No events to display
Investor Contact
For more investor information, Please contact:
Elizabeth Williams, Chief Financial Officer
Email Alerts
* Required Fields